Renaissance Technologies’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$653K Sell
368,847
-104,595
-22% -$131K ﹤0.01% 2500
2026
Q1
$526K Buy
473,442
+365,441
+338% +$513K ﹤0.01% 2581
2025
Q4
$210K Buy
108,001
+19,601
+22% +$46K ﹤0.01% 2871
2025
Q3
$170K Buy
88,400
+24,100
+37% +$46.1K ﹤0.01% 3164
2025
Q2
$122K Buy
64,300
+1,000
+2% +$1.98K ﹤0.01% 3273
2025
Q1
$108K Buy
63,300
+1,500
+2% +$3.26K ﹤0.01% 3187
2024
Q4
$131K Buy
61,800
+600
+1% +$1.12K ﹤0.01% 3242
2024
Q3
$116K Buy
61,200
+3,600
+6% +$6.39K ﹤0.01% 3233
2024
Q2
$106K Sell
57,600
-17,300
-23% -$37.9K ﹤0.01% 3173
2024
Q1
$125K Buy
74,900
+17,500
+30% +$19.3K ﹤0.01% 3328
2023
Q4
$34K Buy
57,400
+34,000
+145% +$23.2K ﹤0.01% 3509
2023
Q3
$17K Buy
23,400
+7,300
+45% +$5.38K ﹤0.01% 3536
2023
Q2
$14K Buy
16,100
+5,700
+55% +$4.87K ﹤0.01% 3806
2023
Q1
$12K Sell
10,400
-129,200
-93% -$129K ﹤0.01% 3872
2022
Q4
$102K Buy
139,600
+118,300
+555% +$85.6K ﹤0.01% 3610
2022
Q3
$22K Buy
+21,300
New +$32.1K ﹤0.01% 3885
2022
Q1
Sell
-40,100
Closed -$113K 4154
2021
Q4
$113K Buy
+40,100
New +$150K ﹤0.01% 3654
2021
Q2
Sell
-120,407
Closed -$459K 3534
2021
Q1
$459K Buy
120,407
+48,221
+67% +$111K ﹤0.01% 2934
2020
Q4
$78K Buy
+72,186
New +$79.8K ﹤0.01% 3284

Other funds holding ENTX

Renaissance Technologies's ENTX Position: Q2 2026 in Review

Renaissance Technologies reduced its Entera Bio (ENTX) stake by 22% in Q2 2026, selling an estimated $131K and leaving 368,847 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #2500.

Renaissance Technologies first reported a position in ENTX in Q4 2020 and has held it in 19 quarters since. 15 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Renaissance Technologies held 368,847 shares of Entera Bio worth $653K as of Q2 2026.
  • Renaissance Technologies sold 104,595 Entera Bio shares in Q2 2026, an estimated $131K.
  • Entera Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2500 holding.
  • Renaissance Technologies first reported a position in Entera Bio in Q4 2020 and has held it in 19 quarters since.
  • 15 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.